相关实验视频
Updated: Jun 3, 2025

12:09
Studying Food Reward and Motivation in Humans
Published on: March 19, 2014
23.1K
神经性厌食症与较高的大脑片受体可用性有关
Kyoungjune Pak1,2, Jouni Tuisku3,4, Henry K Karlsson3,4,5,6
1Department of Nuclear Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea. ilikechopin@me.com.
Molecular psychiatry
|January 12, 2025
概括
神经性厌食症 (AN) 与大脑奖励区域中片受体 (MOR) 可用性增加有关. 这一发现表明内源性阿片类系统在AN中起着关键作用,可能引导新的治疗开发.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 医疗成像医学成像
背景情况:
- 神经性厌食症 (AN) 是一种严重的精神疾病,影响饮食行为和身体形象.
- 穆阿片类受体 (MOR) 是大脑阿片类系统的组成部分,调节了恒常性和快乐性饮食.
- 了解AN的神经生物学基础对于开发有效治疗方法至关重要.
研究的目的:
- 在神经性厌食症 (AN) 患者中,研究片受体 (MOR) 可用性和大脑葡萄糖吸收 (BGU) 之间的关系.
- 探索内源性阿片类系统在AN病理生理学中的作用.
主要方法:
- 使用[11C]卡芬坦尼尔正子发射断层扫描 (PET) 来测量MOR可用性.
- 在高胰岛素-高血糖时使用的2-deoxy-2[18F]fluoro-D-glucose ([18F]FDG) PET,以评估BGU.
- 包括功能磁共振成像 (fMRI) 和13名AN患者和13名健康对照 (HC) 的全面临床评估.
主要成果:
- 与HC相比,具有AN的个体在尾状和状骨中表现出更高的MOR可用性.
- 在AN组的核 (NAcc) 和丘脑中观察到一种更高的MOR可用性的趋势.
- 没有大脑区域显示AN患者的MOR可用性较低;BGU在AN和HC组之间可比,但与关键奖励处理区域的MOR可用性有负相关.
结论:
- 神经性厌食症与对奖励处理至关重要的大脑区域的MOR可用性增加有关.
- 改变的MOR可用性,尽管不变的BGU,表明内源性阿片类系统在AN中发挥了重要作用.
- 这些发现为探索针对阿片类药物系统在AN治疗中的新疗法战略提供了基础.
相关概念视频
Regulation of Food Intake
185
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
185
Anorexia Nervosa
43
Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
43
Opioid Receptors: Overview
486
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
486
Bulimia Nervosa
46
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
46
Analgesia and Pain Management
480
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
480
Drug Abuse and Addiction: Pharmacological Phenomena
433
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
433

